Schistosomiasis — From Genes to Latrines

  • Franz von Lichtenberg


Schistosoma mansoni, S. haematobium and S. japonicum are widely distributed throughout the tropics (Fig. 1) . By the latest estimates, around 160 million people are infected and 550 million are at risk. In major endemic countries including Brazil, Egypt, the Phillipines and China, the toll of schistosomiasis is now well understood, and government sponsored control efforts are in progress. Effective drugs have become available, and the design of preventive campaigns has been rationalized and improved. Yet, in some of the least developed countries, e.g., around new water impoundments in Senegal and in Botswana (1) , schistosomiasis continues spreading and international health organizations have given up the hope of halting transmission and are concentrating on the less ambitious task of lowering schistosomiasis morbidity.


Adult Worm Schistosoma Mansoni Schistosomiasis Control Water Sanitation Urinary Schistosomiasis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Cook, JA (1990) The Edna McConnell Clark Foundation Annual Report. Philadelphia, WM Fell Co, pp 50–52Google Scholar
  2. 2.
    Newport GR, Agabian N (1990) Molecular biology of schistosomes and filariae. In: Wyler DJ, (ed) Modern parasite biology, cellular, immunological and molecular aspects. New York, WH Freeman and Co, pp 362–383Google Scholar
  3. 3.
    Mott KE, Dixon H (1982) Collaborative study on antigens for immunodiagnosis of schistosomiasis. Bull WHO 60: 729–753,1982PubMedGoogle Scholar
  4. 4.
    Mott KE, Dixon H, Osei-Tutu E, England EC, Ekue K, Tekle A (1985) Indirect screening for Schistosoma haematobium infection: a comparative study in Ghana and Zambia. Bull WHO 63: 135–142PubMedGoogle Scholar
  5. 5.
    Stephenson LS Latham MC, Kinoti SN, Oduori ML (1984) Sensitivity and specificity of reagent strips in screening of Kenyan children for Schistosoma haematobium infection. Am J Trop Med Hyg 33: 862–871PubMedGoogle Scholar
  6. 6.
    Doehring-Schwerdtfeger E, Mohamed-Ali G, Abdel-Rahim IM, Kardorff R, Franke D, Kaiser C, Elsheik M, Ehrich JH (1989) Sonomorphological abnormalities in Sudanese children with Schistosoma mansoni infection. A proposed staging-system for field diagnosis of periportal fibrosis. AmJ Trop Med Hyg 41: 63–69Google Scholar
  7. 7.
    Degremont A, Burki A, Burnier E, Schweizer W, Meudt R, Tanner M (1985) Value of ultrasonography in investigating morbidity due to Schistosoma haematobium infection. Lancet 1: 662–665PubMedCrossRefGoogle Scholar
  8. 8.
    Brand JA, Tsang VC (1989) A rapid immnunoblot assay (Western blot) to detect specific antibodies for human immunodeficiency virus, Schistosoma mansoni and Taenia solium (Cysticercosis) . J Immunoassay 10: 237–255PubMedCrossRefGoogle Scholar
  9. 9.
    Gazzinelli G, Lambertucci JR, Katz N, Rocha RS, Lima MS, Colley DG (1985) Immnune responses during human schistosomiasis mansoni. XI.-Immunologic status of patients with acute infections and after treatment. J Immunol 135: 2121–2127PubMedGoogle Scholar
  10. 10.
    Nash, TE (1974) Localization of the circulating antigen within the gut of Schistosoma mansoni. Am J Trop Med Hyg 23: 1085–1087PubMedGoogle Scholar
  11. 11.
    Deelder AM, Kornelis D, Van Marck EAE, Eveleigh PC, Van Egmond JG (1980) Schistosoma mansoni: characterization of two circulating polysaccharide antigens and the immunoglobulin response to these antigens in mouse, hamster and human infection. Exp Parasi to 150: 16–32CrossRefGoogle Scholar
  12. 12.
    El Meanawy MA, Aji T, Phillips NFB, Davis RE, Salata RA, Malhotra I, McClain D, Aikawa M, Davis AH (1990) Definition of the complete Schistosoma mansoni hemoglobinase mRNA sequence and gene expression in developing parasites. Amn J Trop Med Hyg 43: 67–78Google Scholar
  13. 13.
    De Jonge N, Gryseels B, Hilberath GW, Polderman AM, Deelder AM (1988) Detection of circulating anodic antigen by ELISA for seroepidemiology of schistosomiasis mansoni. Trans R Soc Trop Med Hyg 82: 591–594PubMedCrossRefGoogle Scholar
  14. 14.
    Smith JH, Christie JD (1986) The pathobiology of Schistosoma haematobium infection in humans. Human Pathol 17: 333–345CrossRefGoogle Scholar
  15. 15.
    Andrade ZA (1988) Schisto in Brazil ... and how it was fought. World Health, pp 26–27Google Scholar
  16. 16.
    Craig III SP,McKerrow JH, Wang CC (1988) Analysis of DNA encoding the hypoxanthine-guanine phosphoribosyltransferase of Schistosoma mansoni: A putative target for chemotherapy. Nucleic Acids Res 16: 7087–7101PubMedCrossRefGoogle Scholar
  17. 17.
    el Kouni MH, Me ss ier NJ, Cha S (1987) Treatment of schistosomiasis by purine nucleoside analogues in combination with nucleoside transport inhibitors. Biochem Pharmacol 36: 3815–3821PubMedCrossRefGoogle Scholar
  18. 18.
    Chen GZ, Foster L, Bennett JL (1990) Antischistosomal action of mnenivolin: evidence that 3-hydroxy-methylglutaryl-coenzyme A reductase activity in Schistosoma mansoni is vital for parasite survival. Naunyn Schmiedeberg Arch Pharmacol 324: 477–482Google Scholar
  19. 19.
    Holy JM, O’Leary KA, Oaks JA, Tracy JW (1989) Immunocytochemical localization of the major glutathione S-transferases in adult Schistosoma mansoni. J Parasitol 75: 181–190PubMedCrossRefGoogle Scholar
  20. 20.
    Archer, S (1985) The chemotherapy of schistosomiasis. Ann Rev Pharmacol Toxicol 25: 485–508CrossRefGoogle Scholar
  21. 21.
    Utroska JA, Chen MG, Dixon H, Yoon S, Helling-Borda M, Hogerzeil HV, Mott KE (1989) An estimate of global needs for praziquantel within schistosomiasis control programmes. Document WHO/Schisto/89.102 (Distr. Limited) . Geneva, WHOGoogle Scholar
  22. 22.
    von Lichtenberg F, Sadun EH, Cheever AW, Erickson DG, Johnson AJ, Boyce HW (1971) Experimental infection with Schiistosoma japonicum in chimpanzees. Parasitologic, clinical, serologic and pathologic observations. Amn J Trop Med Hyg 20: 850–893Google Scholar
  23. 23.
    Scrimgeour EM, Gajdusek DC (1985) Involvement of the central nervous system in Schistosoma mansoni and S. haematobium infection, a review. Brain 108: 1023–1038PubMedCrossRefGoogle Scholar
  24. 24.
    Gryseels B (1990) Morbidity and Morbidity Control of Schistosomiasis mansoni in Subsaharan Africa. Thesis, U of Leiden. CIP — Gegevens Koninklije Bibliotheek den Haag, pp 150–151Google Scholar
  25. 25.
    Butterworth AE, Hagan P (1987) Immunity in human schistosomiasis. Parasitol Today 3: 11–16PubMedCrossRefGoogle Scholar
  26. 26.
    Butterworth AE (1990) Immunology of Schistosomiasis. In: Wyler DJ (ed) Modern parasite biology. Cellular, immunological and molecular aspects. New York, WH Freeman & Co, p 263Google Scholar
  27. 27.
    Jordan P (1985) “Schistosomiasis: The St. Lucia Project”. Cambridge, University Press, p 442Google Scholar
  28. 28.
    Polderman AM, Manshande JP (1981) Failure of targeted mass treatment to control schistosomiasis. Lancet 1: 27–28PubMedCrossRefGoogle Scholar
  29. 29.
    Hobbs III HH, Jass JP, Huner JV (1989) A review of global crayfish introductions with particular emphasis on two North American species (Decapoda, Cambaridae) . Crustaceana 56: 299–316CrossRefGoogle Scholar
  30. 30.
    McCullough FS (1981) Biological control of the snail intermediate hosts of human Schistosoma sp.: A review of its present status and future prospects. Acta Trop 38: 5–13PubMedGoogle Scholar
  31. 31.
    Pan CT (1956) Studies on the biological control of schistosome-bearing snails; a preliminary report on micro-organisms found in Australorbis glabrata. J Parasitol 42: 33CrossRefGoogle Scholar
  32. 32.
    Lemma A, Goll P, Duncan J, Mazengia B (1978) Control of schistosomiasis with use of endod in Adwa, Ethiopia: Results of a five-year study. In: Proceedings of the International Conference on Schistosomiasis, Vol. 1 415–136, Cairo, Ministry of HealthGoogle Scholar
  33. 33.
    Mott KE (1987) (ed) Plant molluscicides. Chichester, John Wiley & Sons Ltd, p 325Google Scholar
  34. 34.
    Mobarak AB (1982) The schistosomiasis problem in Egypt. Am J Trop Med Hyg 31: 87— 91PubMedGoogle Scholar
  35. 34.
    Mobarak AB (1982) The schistosomiasis problem in Egypt. Am J Trop Med Hyg 31: 87– 91PubMedGoogle Scholar
  36. 36.
    Cherfas J (1991) New hope for vaccine against schistosomiasis. Science 251: 630–631PubMedCrossRefGoogle Scholar
  37. 37.
    Vogel H, Minning W (1953) Uber die erworbene Resistenz von Macaca rhesus gegenüber Schistosoma japonicum. Zeitschr Tropenmed Parasitol 4: 418–505Google Scholar
  38. 38.
    Villela JB, Gomberg HJ, Gould SE (1961) Immunization of Schistosoma mansoni in mice inoculated with irradioated cercariae. Science 134: 1073–1075CrossRefGoogle Scholar
  39. 39.
    Sher FA, Colley DG (1989) Immunoparasitology. In: Paul WE (ed) Fundamental immunology. New York, Raven Press, pp 957–983Google Scholar
  40. 40.
    Dean DA, Mangold BL, Kassim OO, von Lichtenberg F (1987) Sites and mechanisms of schistosome elimination. Mem Inst Oswaldo Cruz, Rio de Janeiro: 82 [Suppl IV] 31–37CrossRefGoogle Scholar
  41. 41.
    Butterworth AE, Bensted-Smith R, Capron A, Capron M, Dalton PR, Dunne DW, Grzych JM, Kariuki HC, Khalife J, Koech D, Mugambi M, Ouma JH, Arap-Siongok TK, Sturrock RF (1987) Immunity in human schistosomniasis mansoni. Prevention by blocking antibodies of the expression of immunity in young children. Parasitology 94: 269–280PubMedCrossRefGoogle Scholar
  42. 42.
    Pearce EJ, Caspar P, Grzych JM, Lewis FA, Sher A (1991) Down regulation of Th 1 cytokine production accompanies induction of Th2 responses by a parasite helminth, Schistosoma mansoni. J Exp Med 173: 159–166PubMedCrossRefGoogle Scholar
  43. 43.
    Webbe G, Sturrock RF, James ER, James C (1982) Schistosoma haematobium in the baboon (Papio anubis) : effect of vaccination with irradiated larvae on the subsequent infection with percutaneously applied cercariae. Trans R Soc Trop Med Hyg 76: 354–361PubMedCrossRefGoogle Scholar
  44. 44.
    Byram JE, Harrison RA, von Lichtenberg F, Webbe G, Sturrock RF (1989) Pathology resulting from the administration of a live attenuated anti-Schistosoma hiaematobium vaccine in baboons. Am J Trop Med Hyg 40: 55–65PubMedGoogle Scholar
  45. 45.
    WHO (1991) Meeting on strategies for the development of a schistosomiasis vaccine, 15— 16 January 1991, Geneva. Doc. TDR/SCH/VAC-DEV/91.3Google Scholar
  46. 46.
    Health Education in the Control of Schistosomiasis (1990) Geneva, WHO, pp 13–55Google Scholar

Copyright information

© Springer Science+Business Media New York 1992

Authors and Affiliations

  • Franz von Lichtenberg
    • 1
  1. 1.Brigham and Women’s HospitalHarvard Medical SchoolBostonUSA

Personalised recommendations